Use access key #2 to skip to page content.
$39.02 -3.29 (-7.78%)
12/1/2008 4:00 PM

Biogen Idec, Inc. (BIIB)

CAPS Rating:
****

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

View All Commentary (BIIB)

Recs

0

Avatar SuperStocker1 (70.63) Submitted: 8/14/08 9:25 PM : Outperform Start Price: $54.86 BIIB Score: 7.94

Recovery breakout upwards

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links